Payal Kohli, MD

VARIOUS

9020 WALKING STICK TRL

Articles

FDA Warns of Ketoacidosis with SGLT2 Inhibitors

July 02, 2015

The Food and Drug Administration (FDA) issued a formal communication warning about the risk of acidosis with the use of SGLT2 inhibitors.